Covidien Ltd. (NYSE: COV; BSX: COV) announced today that its Board
of Directors has declared a quarterly cash dividend of $0.16 per
common share. The dividend is payable on May 5, 2008, to shareholders
of record on March 31, 2008.
In addition, Covidien today announced that it has launched an
Investor Services Program for shareholders. The program offers a
convenient method to reinvest dividends or to buy or sell Covidien
common shares. Additional information is available at Covidien´s web
site: investor.covidien.com
ABOUT COVIDIEN LTD.
Covidien is a leading global healthcare products company that
creates innovative medical solutions for better patient outcomes and
delivers value through clinical leadership and excellence. Covidien
manufactures, distributes and services a diverse range of
industry-leading product lines in four segments: Medical Devices,
Imaging Solutions, Pharmaceutical Products and Medical Supplies. With
2007 revenue of nearly $9 billion, Covidien has more than 43,000
employees worldwide in 57 countries, and its products are sold in over
130 countries. Please visit www.covidien.com to learn more about our
business.
